"Gene_id";"Disease_id";"idMutation";"Mutation_type";"Mutation_name";"gene_position";"protein_position";"effect"
16135;94;1;"Missense Variant";;"c.242G>C";"p.Trp81Ser";
16135;94;2;"Missense Variant";"rs113173389";"c.281G>T/A";"p.Cys94Tyr";"Loss of enzyme activity"
16135;94;3;"Missense Variant";"rs869312134";"c.59C>A";"p.Ala20Asp";"Loss of enzyme activity"
16135;94;4;"Missense Variant";"rs104894847";"c.58G>C ";"p.Ala20Pro";"Loss of enzyme activity"
16135;94;5;"Missense Variant";"rs869312142";"c.337T>A";"p.Pro113Ile";"Decreased enzyme activity"
16135;94;6;"Missense Variant";"rs869312138";"c.107T>G";"p.Leu36Trp";"Loss of enzyme activity"
16135;94;7;"Missense Variant";"rs28935488";"c.806T>C";"p.Val269Ala";"Loss of enzyme activity"
16135;94;8;"Missense Variant";"rs869312156";"c.943G>A";"p.Asp315Asn";"Decreased enzyme activity"
16135;94;9;"Missense Variant";"rs869312160";"c.980A>T";"p.Gln327Leu";"Loss of enzyme activity"
16135;94;10;"Missense Variant";"rs104894832";"c.982G>C";"p.Gly328Arg";"Loss of enzyme activity"
16240;12381;11;"Missense Variant";"rs121965021";"c.1598C>T";"p.Pro533Leu";"Reduces catalytic activity and protein stability"
16240;12381;12;"Missense Variant";"rs758452450";"c.223G>A";"p.Ala75Thr";"Pathogenic"
16240;12381;13;"Missense Variant";"rs558683362";"c.399G>C";"p.Met133Ile";"Uncertain significance"
16240;12381;14;"Missense Variant";"rs368454909";"c.1045G>T";"p.Asp349Tyr";"Pathogenic/Likely pathogenic"
16240;12381;15;"Missense Variant";"rs121965024";"c.1096A>C";"p.Thr366Pro";"Pathogenic"
16240;12381;16;"Missense Variant";"rs1430681871";"c.623G>A";"p.Gly208Asp";"Pathogenic/Likely pathogenic"
16240;12382;17;"Missense Variant";"rs931627770";"c.1269C>A";"p.Ser423Arg";"Significant reduction of activity and protein levels"
16240;12382;18;"Missense Variant";"rs121965029";"c.266G>A";"p.Arg89Gln";"Pathogenic"
16240;12382;19;"Missense Variant";"rs794726878";"c.53T>C";"p.Leu18Pro";"Conflicting classifications of pathogenicity: Pathogenic/Likely pathogenic/Uncertain significance"
16240;12382;20;"Missense Variant";"rs121965026";"c.1475G>C";"p.Arg492Pro";"Likely pathogenic"
16240;12382;21;"Missense Variant";"rs746766617";"c.1044C>G";"p.Asn348Lys";"Pathogenic/Likely pathogenic"
16240;12382;22;"Missense Variant";"rs780165694";"c.227A>G";"p.Tyr76Cys";"Conflicting classifications of pathogenicity: Likely pathogenic/Uncertain significance"
16240;12383;23;"Missense Variant";"rs747981483";"c.236C>T";"p.Ala79Val";"Reduction of activity and protein levels"
16240;12383;24;"Missense Variant";"rs148789453";"c.713T>A";"p.Leu238Gln";"Pathogenic/Likely pathogenic"
16240;12383;25;"Missense Variant";"rs369090960";"c.793G>C";"p.Gly265Arg";"Pathogenic/Likely pathogenic"
16240;12383;26;"Missense Variant";"rs750496798";"c.1087C>T";"p.Arg363Cys";"Loss of activity"
16240;12383;27;"Missense Variant";"rs931627770";"c.1269C>A";"p.Ser423Arg";"Significant reduction of activity and protein levels"
16240;12383;28;"Missense Variant";"rs121965021";"c.1598C>T";"p.Pro533Leu";"Reduces catalytic activity and protein stability"
16239;18824;29;"Missense Variant";"rs398123249";"c.262C>T";"p.Arg88Cys";"Pathogenic"
16239;18824;30;"Missense Variant";"rs2089497431";"c.263G>A";"p.Arg88His";"Poor transport to lysosomes"
16239;18824;31;"Missense Variant";"rs2089497300";"c.275T>C";"p.Leu92Pro";"Likely pathogenic"
16239;18824;32;"Missense Variant";"rs193302911";"c.359C>G";"p.Pro120Arg";"Likely pathogenic"
16239;18824;33;"Missense Variant";"rs145807417";"c.925A>G";"p.Thr309Ala";
16239;18824;34;"Missense Variant";"rs104894853";"c.998C>T";"p.Ser333Leu";"Pathogenic"
16239;18825;35;"Missense Variant";"rs1569560528";"c.143G>C";"p.Arg48Pro";"Likely pathogenic"
16239;18825;36;"Missense Variant";"rs113993954";"c.212G>A";"p.Ser71Asn";"Pathogenic"
16239;18825;37;"Missense Variant";"rs193302911";"c.359C>A";"p.Pro120His";"Pathogenic"
16239;18825;38;"Missense Variant";"rs199422229";"c.1264T>G";"p.Cys422Gly";"Pathogenic/Likely pathogenic"
16239;18825;39;"Missense Variant";"rs864622773";"c.1433A>G";"p.Asp478Gly";"Pathogenic"
16239;18825;40;"Missense Variant";"rs2089303696";"c.1568A>G";"p.Tyr523Cys";"Likely pathogenic"
15285;11295;41;"Missense Variant";"rs139850991";"c.96C>A";"p.Asp32Glu";"Uncertain significance"
15285;11295;42;"Missense Variant";"rs1057521146";"c.130G>A";"p.Ala44Thr";"Conflicting classifications of pathogenicity: Likely pathogenic/Uncertain significance"
15285;11295;43;"Missense Variant";"rs104894636";"c.220C>T";"p.Arg74Cys";"The mutant is enzymatically inactive; rapid degradation rather than decrease in synthesis is responsible for the low steady state level of the mutant protein in cells"
15285;11295;44;"Missense Variant";"rs753666460";"c.571G>A";"p.Gly191Arg";"The mutant is enzymatically inactive; rapid degradation rather than decrease in synthesis is responsible for the low steady state level of the mutant protein in cells"
15285;11295;45;"Missense Variant";"rs104894643";"c.617G>C";"p.Arg206Pro";"The mutant enzyme retains 8% residual activity"
15285;11295;46;"Missense Variant";"rs772311757";"c.1129C>T";"p.Arg377Cys";"Does not yield active enzyme; the reduction in 62 kDa precursor and 56 kDa mature forms suggests an increased degradation of the mutant enzyme"
16514;11296;47;"Missense Variant";"rs1599253805";"c.230T>G";"p.Val77Gly";"Decreases the enzyme activity markedly"
16514;11296;48;"Missense Variant";"rs1599253815";"c.245G>A";"p.Gly82Asp";"No enzyme activity; synthesizes a polypeptide with a molecular size similar to that of the wild-type"
16514;11296;49;"Missense Variant";"rs770684838";"c.461T>G";"p.Ile154Arg";"Does not yield active enzyme"
16514;11296;50;"Missense Variant";"rs104894598";"c.1694G>C";"p.Arg565Pro";"Does not yield active enzyme"
16514;11296;51;"Missense Variant";"rs527236037";"c.1949G>A";"p.Gly650Glu";"Pathogenic/Likely pathogenic"
16514;11296;52;"Missense Variant";"rs1364203992";"c.2113G>A";"p.Glu705Lys";"Conflicting classifications of pathogenicity: Pathogenic/Likely pathogenic/Uncertain significance"
16197;11297;53;"Missense Variant";"rs112029032";"c.1843G>A";"p.Ala615Thr";"Uncertain significance; may act as a modifier of disease severity in patients with retinitis pigmentosa; has a negligible effect on the enzyme expression; moderately reduced enzyme activity"
16197;11297;54;"Missense Variant";;;"p.Ala82Val";"Shows practically no enzyme activity"
16197;11297;55;"Missense Variant";;;"p.Gly290Arg";"Results in a negligible amount of protein synthesis; very low enzyme activity; retained in the endoplasmic reticulum"
16197;11297;56;"Missense Variant";;;"p.Arg372Cys";"Results in a negligible amount of protein synthesis; very low enzyme activity; retained in the endoplasmic reticulum"
16197;11297;57;"Missense Variant";;;"p.Gly452Val";"Shows practically no enzyme activity"
16197;11297;58;"Missense Variant";;;"p.Met510Lys";"Results in a negligible amount of protein synthesis; very low enzyme activity; retained in the endoplasmic reticulum"
16095;21369;59;"Missense Variant";"rs794729202";"c.47T>A";"p.Val16Glu";"Reduced enzymatic activity"
16095;21369;60;"Missense Variant";"rs141340188";"c.251C>A";"p.Ala84Glu";"Loss of enzymatic activity"
16095;21369;61;"Missense Variant";"rs577334837";"c.433C>T";"p.His145Tyr";"Reduced enzymatic activity"
16095;21369;62;"Missense Variant";"rs267606838";"c.1019G>A";"p.Gly340Asp";"Pathogenic/Likely pathogenic"
16095;21369;63;"Missense Variant";"rs770908172";"c.1138A>G";"p.Arg380Gly";"Loss of enzymatic activity"
16095;21369;64;"Missense Variant";"rs142822371";"c.1247T>C";"p.Ile416Thr";"Reduced enzymatic activity"
16136;21370;65;"Missense Variant";"rs1553612220";"c.248A>G";"p.Tyr83Cys";"Decrease in galactosidase activity"
16136;21370;66;"Missense Variant";"rs778700089";"c.446C>T";"p.Ser149Phe";"2.0% of wild-type galactosidase activity"
16136;21370;67;"Missense Variant";"rs72555369";"c.1223A>C";"p.Gln408Pro";"1.1% of wild-type galactosidase activity"
16136;21370;68;"Missense Variant";"rs72555365";"c.1444C>T";"p.Arg482Cys";"Loss of galactosidase activity"
16136;21370;69;"Missense Variant";"rs968221254";"c.1452C>G";"p.Asn484Lys";"Fibroblasts from MPS4B compound heterozygotes for K-484 and A-500 have 1.9% of wild-type galactosidase activity"
16136;21370;70;"Missense Variant";"rs72555368";"c.1498A>G";"p.Thr500Ala";"2.1% of wild-type galactosidase activity"
15952;20356;71;"Missense Variant";"rs775780931";"c.347C>A";"p.Pro116His";"Uncertain significance"
15952;20356;72;"Missense Variant";"rs118203939";"c.349T>C";"p.Cys117Arg";"Pathogenic/Likely pathogenic"
15952;20356;73;"Missense Variant";"rs746206847";"c.430G>A";"p.Gly144Arg";"Severe reduction of activity"
15952;20356;74;"Missense Variant";"rs779378413";"c.904G>A";"p.Gly302Arg";"Conflicting classifications of pathogenicity: Pathogenic/Likely pathogenic/Uncertain significance"
15952;20356;75;"Missense Variant";"rs759384989";"c.936G>T";"p.Trp312Cys";"Loss of activity"
15952;20356;76;"Missense Variant";"rs1554069661";"c.1562G>A";"p.Cys521Tyr";"Severe reduction of activity"
15952;20357;77;"Missense Variant";"rs751010538";"c.275C>T";"p.Thr92Met";"Conflicting classifications of pathogenicity: Likely pathogenic/Uncertain significance"
15952;20357;78;"Missense Variant";"rs1554087423";"c.574T>C";"p.Cys192Arg";"Severe reduction of activity"
15952;20357;79;"Missense Variant";"rs118203940";"c.707T>C";"p.Leu236Pro";"Conflicting classifications of pathogenicity: Pathogenic/Uncertain significance"
15952;20357;80;"Missense Variant";"rs1554079320";"c.962T>C";"p.Leu321Pro";"Severe reduction of activity"
15952;20357;81;"Missense Variant";"rs118203941";"c.1214G>A";"p.Cys405Tyr";"Conflicting classifications of pathogenicity: Pathogenic/Likely pathogenic/Uncertain significance"
15952;20357;82;"Missense Variant";"rs1554069659";"c.1592C>G";"p.Pro531Arg";"Uncertain significance"
16179;40;83;"Missense Variant";"rs121918177";"c.442C>T";"p.Pro148Ser";"Pathogenic"
16179;40;84;"Missense Variant";"rs121918181";"c.526C>T";"p.Leu176Phe";"Pathogenic"
16179;40;85;"Missense Variant";"rs121918174";"c.646C>T";"p.Arg216Trp";"Pathogenic/Likely pathogenic"
16179;40;86;"Missense Variant";"rs121918173";"c.1144C>T";"p.Arg382Cys";"Pathogenic/Likely pathogenic"
16179;40;87;"Missense Variant";"rs764018631";"c.1145G>A";"p.Arg382His";"Pathogenic/Likely pathogenic"
16179;40;88;"Missense Variant";"rs779091113";"c.1222C>T";"p.Pro408Ser";"Uncertain significance"
16136;11281;89;"Missense Variant";"rs756878418";"c.175C>T";"p.Arg59Cys";"Loss of galactosidase activity"
16136;11281;90;"Missense Variant";"rs72555392";"c.176G>A";"p.Arg59His";"With cardiac involvement in some patients; loss of galactosidase activity"
16136;11281;91;"Missense Variant";"rs28934274";"c.367G>A";"p.Gly123Arg";"Decrease in galactosidase activity"
16136;11281;92;"Missense Variant";"rs397515617";"c.518T>C";"p.Leu173Pro";"Loss of galactosidase activity"
16136;11281;93;"Missense Variant";"rs756575833";"c.569G>A";"p.Gly190Asp";"3.4% of wild-type galactosidase activity"
16136;11281;94;"Missense Variant";"rs746766232";"c.716C>T";"p.Thr239Met";"Loss of galactosidase activity; severe mutation; causes a rapid degradation of the protein precursor"
16136;11282;95;"Missense Variant";"rs572237881";"c.203G>A";"p.Arg68Gln";"7.4% of wild-type galactosidase activity"
16136;11282;96;"Missense Variant";"rs377174858";":c.785G>C";"p.Gly262Ala";"Decrease in galactosidase activity"
16136;11282;97;"Missense Variant";"rs752177002";"c.1010T>C";"p.Leu337Pro";"Loss of galactosidase activity"
16136;11282;98;"Missense Variant";"rs1172435886";"c.1479G>T";"p.Lys493Asn";"Decrease in galactosidase activity"
16136;11282;99;"Missense Variant";"rs746350513";;"p.Gly579Asp";"Loss of galactosidase activity"
16136;11282;100;"Missense Variant";"rs398123351";"c.1769G>A";"p.Arg590His";"Pathogenic/Likely pathogenic"
16136;11283;101;"Missense Variant";"rs72555390";"c.152T>C";"p.Ile51Thr";"No effect on catalytic activity; decreased protein stability"
16136;11283;102;"Missense Variant";"rs72555393";"c.245C>T";"p.Thr82Met";"Conflicting classifications of pathogenicity:Pathogenic/Likely pathogenic/Uncertain significance"
16136;11283;103;"Missense Variant";"rs1214295886";"c.797A>G";"p.Asn266Ser";"Uncertain significance"
16136;11283;104;"Missense Variant";"rs376663785";"c.808T>G";"p.Tyr270Asp";"Pathogenic/Likely pathogenic, originally classified as Morquio syndrome"
16136;11283;105;"Missense Variant";"rs28934886";"c.1370G>A";"p.Arg457Gln";"Pathogenic/Likely pathogenic"
16136;11283;106;"Missense Variant";"rs4302331";"c.1561T>C";"p.Cys521Arg";"Likely benign; galactosidase activity is reduced in homozygous patient fibroblasts to 30% of control values; has 25% of wild-type galactosidase activity when expressed in a heterologous system"
16106;11102;107;"Missense Variant";"rs1141814";"c.259C>T";"p.Arg87Trp";"Decreased glucosylceramidase activity"
16106;11102;108;"Missense Variant";"rs121908312";"c.354G>C";"p.Lys118Asn";"Decreased glucosylceramidase activity; 8% of normal activity; increases susceptibility to proteolytic degradation"
16106;11102;109;"Missense Variant";"rs77834747";"c.473T>C";"p.Ile158Thr";"Very low glucosylceramidase activity"
16106;11102;110;"Missense Variant";"rs381427";"c.689T>G";"p.Val230Gly";"Very low glucosylceramidase activity"
16106;11102;111;"Missense Variant";"rs121908298";"c.983C>T";"p.Pro328Leu";"Loss of glucosylceramidase activity"
16106;11102;112;"Missense Variant";"rs76763715";"c.1226A>G";"p.Asn409Ser";"Risk factor for Parkinson disease; increased proteasomal degradation; decreased protein abundance; decreased glucosylceramide catabolic process; decreased glucosylceramidase activity; 23% of normal activity when expressed in a heterologous system; alters interaction with saposin-C"
16106;11103;113;"Missense Variant";"rs398123530";"c.508C>T";"p.Arg170Cys";"Pathogenic; also found in a patient with Parkinson disease"
16106;11103;114;"Missense Variant";"rs773409311";"c.709A>G";"p.Lys237Glu";"Loss of glucosylceramidase activity; increases susceptibility to proteolytic degradation"
16106;11103;115;"Missense Variant";"rs78973108";"c.887G>A";"p.Arg296Gln";"Pathogenic; also found in a patient with Parkinson disease"
16106;11103;116;"Missense Variant";"rs1553217009";"c.1312G>A";"p.Asp438Asn";"Decreased glucosylceramidase activity; 14% of normal activity; increases susceptibility to proteolytic degradation"
16106;11103;117;"Missense Variant";"rs1064651";"c.1342G>C";"p.Asp448His";"At homozygosity it causes GD3C; also found in a patient with Parkinson disease; loss of glucosylceramidase activity; alters protein stability"
16106;11103;118;"Missense Variant";"rs421016";"c.1448T>C";"p.Leu483Pro";"Risk factor for Parkinson disease; gene conversion; alters protein stability; increased proteasomal degradation; decreased protein abundance; very low glucosylceramide catabolic process; severe decrease of glucosylceramidase activity; 3% of normal activity when expressed in a heterologous system"
16106;11104;119;"Missense Variant";"rs758447515";"c.437C>T";"p.Ser146Leu";"Conflicting classifications of pathogenicity:Pathogenic/Likely pathogenic/Uncertain significance"
16106;11104;120;"Missense Variant";"rs765633380";"c.970C>T";"p.Arg324Cys";"Conflicting classifications of pathogenicity:Pathogenic/Uncertain significance"
16106;11104;121;"Missense Variant";"rs80356769";"c.1297G>T";"p.Val433Leu";"Decreased glucosylceramidase activity; 12% of normal activity"
16106;11104;122;"Missense Variant";"rs1064651";"c.1342G>C";"p.Asp448His";"At homozygosity it causes GD3C; also found in a patient with Parkinson disease; loss of glucosylceramidase activity; alters protein stability"
16106;11104;123;"Missense Variant";"rs77369218";"c.1343A>T";"p.Asp448Val";"Loss of glucosylceramidase activity; results in glycosphingolipid accumulation in brain and liver of a knockin mouse model due to impaired glucosylceramidase activity"
16106;11104;124;"Missense Variant";"rs421016";"c.1448T>C";"p.Leu483Pro";"Risk factor for Parkinson disease; gene conversion; alters protein stability; increased proteasomal degradation; decreased protein abundance; very low glucosylceramide catabolic process; severe decrease of glucosylceramidase activity; 3% of normal activity when expressed in a heterologous system"
